Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.
about
Experimental endocarditis: prophylaxis of Candida albicans infections by 5-fluorocytosine in rabbitsBacterial adhesion in the pathogenesis of infective endocarditis. Effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rabbitsComparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbitsComparative capacity of orally administered amoxicillin and parenterally administered penicillin-streptomycin to protect rabbits against experimentally induced streptococcal endocarditis.Right atrial pressure alterations during echocardiography-guided-catheterization predict tricuspid valvular impairment: a novel method for the creation of a rabbit model of Staphylococcus aureus endocarditis.Principles of combination therapy.Experimental Bacteroides fragilis endocarditis in rabbits.Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans.Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis.Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.Daptomycin (LY146032) treatment of experimental enterococcal endocarditisInvolvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditisComparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis.Enoxacin compared with cefoperazone for the treatment of experimental Enterobacter aerogenes endocarditis.Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis.Cefoperazone treatment of experimental endocarditis.Aztreonam, cefoperazone, and gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis in rabbits.Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.Clindamycin and dentistry.Natural history of aortic valve endocarditis in ratsProsthetic valve endocarditis: a review of 24 cases.Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin.Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditisChemotherapy of experimental streptococcal endocarditis. 3. Failure of a bacteriostatic agent (tetracycline) in prophylaxisWho decides on the need for antibiotic prophylaxis in patients with major arthroplasties requiring dental treatment: is it a joint responsibility?Vancomycin prophylaxis of experimental Streptococcus sanguis. Inhibition of bacterial adherence rather than bacterial killing.Efficacy of antibiotic prophylactic regimens for the prevention of bacterial endocarditis of oral origin.Bacterial endocarditis due to penicillin-resistant Streptococcus viridans.Antibiotic tolerance among clinical isolates of bacteria.Tolerance and efficacy of parenterally administered penicillin-streptomycin and orally administered amoxicillin or penicillin V for prophylaxis of experimentally induced streptococcal endocarditis.Gastrointestinal instrumentation, bacteraemia, and endocarditis.Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococciInduction and prevention of experimental arteriovenous fistula infections.The 1976 Paul B. Beeson lecture. Some observations on experimental endocarditis.Rat model of experimental endocarditisCurrent practice in prevention of bacterial endocarditis.Garenoxacin treatment of experimental endocarditis caused by viridans group streptococci.Enhanced in vitro bactericidal activity of amikacin or gentamicin combined with three new extended-spectrum cephalosporins against cephalothin-resistant members of the family Enterobacteriaceae.Antibiotic prophylaxis patterns of Finnish dentists performing dental implant surgery.
P2860
Q28325205-86C2A35A-5B7D-40A1-A6B7-BF8FA3D0D482Q30449847-45DDF85F-3304-4A3B-91D0-5B894191A40BQ33734666-FBBB65DE-335F-4272-A17D-89116252C281Q33739599-E5C8631B-028A-467B-B55A-085E906ECD58Q33832213-310CCE28-542B-4884-8235-B75E769526CBQ34053701-BE57CF16-5B8E-419F-8B15-F01FD1A6A1C4Q34427730-F3A5952A-EB4F-4CBE-B1E4-90ACED06ECC7Q34931562-AB722B2B-45FD-421C-9BF6-68A05C5CBFB0Q35137532-EA4C5606-ED38-4112-9FCA-D3E23213E9FCQ35195045-7DE85FE4-AF92-4EC8-937F-A4A272F4D0AFQ35292551-894287CA-831D-4B20-B809-80A7819E3B6DQ35309352-CBE7926E-5F9A-4B57-96E5-F0DB9C00DC62Q35387312-CF34F0F6-0391-40C0-A20C-B4E77F51735FQ35537958-FE294A89-C3D5-4A2E-8A2D-484963798B76Q35643969-421EB256-9A5D-4BFE-BDA6-E9162809B320Q35648839-5BDBC9B9-3F08-491E-92B7-7D6435C10AA4Q35669584-6C034959-0234-4D8B-A645-A472E3E2AAD0Q35753847-4DA3329A-4634-4D8D-8F64-A774E85AEB7CQ35759063-1D3ADA8D-1541-4305-9D58-889132272919Q36186503-1F92F529-287D-42B8-979A-C2D16E8E61C9Q36328909-81CE87EB-83EB-4A9C-BA75-B50D77A3158DQ36445819-35B95C98-540B-430E-943F-EA43CCF54F0FQ36465560-DF7027EF-C97E-42BA-9E6C-C83DE0B421D4Q36480737-124DDDAE-104F-453D-8A24-4594BE824432Q36659698-03B24087-8D26-4F7F-8E20-15BA67E31223Q36821333-0E98B7D6-2968-445A-836B-8E765559E0A1Q37004648-E4BD5A51-A628-4BBF-A397-FC1762DD0F1EQ37014023-7122398F-9260-415A-AA7B-E2D0EB4FB67FQ39664887-AFD47287-5CE2-4666-B5E5-5009F9FCA1F8Q39750871-BA666663-8BB5-4289-BF1A-014CD689786FQ39815409-A63CD01F-43DF-4815-B13C-9AABA13748A8Q40160347-39968366-9B10-4C04-B29E-689428B6CC64Q40528501-DFCECB1F-D82C-40A9-A7BE-FC4F5CA10FCAQ40621285-97FBE70B-3E27-42A0-923F-9021F11EE2D6Q40761560-4F7DD8A8-0D73-4E0B-90DF-66DD61CE6EB1Q40912533-0C0B483A-B737-4187-B5BD-1CD413B38B5EQ41324665-C0B7023C-EDC3-4AB7-8798-2B7FD994BBB0Q41992616-33E5E0DF-EC47-4D3D-A89B-88CAF4BF1ED4Q42250732-FD8920B3-F723-46B1-A0B1-D349FDB97D3EQ47598530-74233E86-711C-4D85-8952-715BB4ED637C
P2860
Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.
description
1973 nî lūn-bûn
@nan
1973 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի մարտին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Chemotherapy of experimental s ...... mmended prophylactic regimens.
@ast
Chemotherapy of experimental s ...... mmended prophylactic regimens.
@en
Chemotherapy of experimental s ...... mmended prophylactic regimens.
@nl
type
label
Chemotherapy of experimental s ...... mmended prophylactic regimens.
@ast
Chemotherapy of experimental s ...... mmended prophylactic regimens.
@en
Chemotherapy of experimental s ...... mmended prophylactic regimens.
@nl
prefLabel
Chemotherapy of experimental s ...... mmended prophylactic regimens.
@ast
Chemotherapy of experimental s ...... mmended prophylactic regimens.
@en
Chemotherapy of experimental s ...... mmended prophylactic regimens.
@nl
P2860
P356
P1476
Chemotherapy of experimental s ...... mmended prophylactic regimens.
@en
P2093
Petersdorf RG
P2860
P304
P356
10.1172/JCI107220
P407
P577
1973-03-01T00:00:00Z